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Electrical isolation of the pulmonary veins (PV) has become a curative treatment for
patients with atrial ﬁbrillation (AF). Recently, there have been many reports that circum-
ferential PV isolation (CPI) on the atrial side has a better outcome than segmental ostial PV
isolation (SOPI). However, reports on the combination of CPI using electoroanatomic
mapping and SOPI using a circular mapping catheter have been few. The aim of the present
study was to investigate the eﬃcacy and safety of a combined therapy using CPI and
supplemental SOPI for the treatment of AF. We performed CPI in 120 patients with drug-
refractory AF. In 27 of those patients CPI resulted in a disconnection between the left atrium
(LA) and PVs. In the remaining patients, supplemental SOPI completed the LA-PV
disconnection. After an average follow-up period of 10.4 months, 81.7%, 90.5% and 71.4% of
the patients with paroxysmal, persistent and chronic AF, respectively, have been free of AF.
In 14.1% of the patients with paroxysmal AF, a greatly reduced frequency and/or duration of
the episodes of AF were observed after the ablation. No fatal complications were encountered.
The present results suggest that the combination of CPI and supplemental SOPI is eﬃcient
and safe for the treatment of AF.
(J Arrhythmia 2006; 22: 225–233)
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Introduction
Electrical isolation of pulmonary veins (PVs) has
become a curative treatment for patients with drug
refractory atrial ﬁbrillation (AF). Initially, isolation
of the PVs was performed segmentally at the ostia of
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the PVs using a circular mapping catheter.1–4)
However, subsequent reports showed that circum-
ferential PV isolation (CPI) on the atrial side had a
better outcome as compared with segmental ostial
PV isolation (SOPI).5–8) However, reports on the
combination of encircling PV isolation using elec-
toroanatomic mapping (CARTO Biosense) and
segmental ostial PV isolation using a circular
mapping catheter have been sparse.9–11) The present
study aimed to investigate the eﬃcacy and safety of
a combined therapy using encircling PV isolation
and supplemental segmental ostial isolation for the
treatment of AF. Although a randomized prospective
study is required to determine which is the best of
the three methods (CPI, SOPI or CPIþ SOPI), the
purpose of the present study was to examine the
usefulness of supplemental SOPI after CPI.
Methods
Study population
One hundred and twenty consecutive patients with
drug-refractory AF were included in the study. All
patients signed an informed consent. ‘‘Persistent AF’’
and ‘‘chronic AF’’ were deﬁned as having AF lasting
for 2 weeks to 6 months and >6 months, respec-
tively. The baseline characteristics of these patients
are presented in Table 1. Segmental ostial PV
isolation was previously performed in seven patients
in whom AF recurred.
Catheter positions
Under the guidance of ﬂuoroscopy a decapolar
catheter (Daig Corp. Minnetonka, MN, USA; or
Irvine Biomedical, Irvine, CA, USA) was inserted
into the coronary sinus through the left subclavian
vein. Access to the left atrial chamber was via a
transseptal puncture guided by intra-cardiac echo-
cardiography using a 9-MHz, 9 French intracardiac
echography (ICE) catheter (Ultra ICE, Boston
Scientiﬁc, San Jose, CA, USA) placed in the right
atrium. Three sheaths (SL12, Daig Corp. Minne-
tonka, MN, USA; and Soft Tip, Boston Scientiﬁc,
San Jose, CA, USA) were introduced into the left
atrium through the atrial septum via the right femoral
vein (in most cases less than two of the three sheaths
were positioned in the left atrium simultaneously).
During left atrial mapping and ablation, heparin was
administered to achieve a serum activated clotting
time >250 seconds.
Two SL1 sheaths were advanced into the left
(or right) superior and inferior pulmonary veins
and selective pulmonary venography was obtained
by injecting contrast medium simultaneously
(Figure 1A). Then the 8.5-French Soft Tip sheath
was introduced into the pulmonary veins, and
through the sheath the 9-MHz ICE catheter was
introduced into the pulmonary veins. By pulling
back the ICE catheter the junction between the
pulmonary vein and left atrium was recognized
(Figure 2). Two circular mapping catheters (Lasso
20-pole 15–20mm, Biosense-Webster, CA, USA)
were introduced into the left- and right-sided
superior and inferior pulmonary veins through the
two SL1 sheaths with the ring electrodes positioned
5mm inside from the LA-PV junction (Figure 1B).
The electrograms from the ostia of the pulmonary
veins were recorded with the Lasso catheters using
an EP laboratory system (DUO, Bard, MA, USA). A
Navistar catheter (F-curve, CARTO, Biosense-Web-
ster, CA, USA) was used to construct a three-
dimensional (3-D) shell of the LA including the
mitral annulus and four PVs. Under ﬂuoroscopic
guidance, the PV ostium was tagged on the 3-D map
of the LA (Figure 3A).
Ablation
Radiofrequency (RF) energy was delivered with a
temperature-controlled, 4mm-tip, deﬂectable cathe-
ter (Navistar, Biosense-Webster, CA, USA) with a
target temperature of 55 C and maximum output of
Table 1 Baseline characteristics.
N ¼ 120
Male/female 96/24
Age (years) 59:8 11:0
Type of AF
Paroxysmal 71
Persistent 21
Chronic 28
Previous segmental PV ablation 7
Failed antiarrhythmic drugs 2:7 1:1
Underlying heart disease
Lone AF 69
Hypertensive heart disease 15
Hypertrophic cardiomyopathy 7
Sick sinus syndrome 7
Chronic renal failure on
regular hemodialysis 7
Dilated cardiomyopathy 6
Oschemic heart disease 5
Others 4
Left atrial size (mm) 37:1 8:2
LVEF (%) 60:0 11:8
LVEF: left ventricular ejection fraction
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A   pulmonary venography
B   catheter position
Left–sided PVs Right–sided PVs
Figure 1 Selective pulmonary venography of
the left PVs and right superior pulmonary vein
(RSPV), and the position of the Lasso catheters in
the pulmonary veins (right anterior oblique view
30).
A, Selective pulmonary venogram (PVram). A left
superior and inferior PVram was obtained by
injecting contrast medium simultaneously via two
SL-1 sheaths. A right inferior PVgram was not
performed because of the diﬃculty in inserting the
SL-1 sheath. B, Position of the Lasso catheters in the
pulmonary veins.
Figure 2 Intravascular echocardiogram of the pulmonary vein (RSPV).
By pulling back the ICE catheter from inside the PV to the LA, the PV-LA junction was clearly recognized. A ﬂuoroscopic view
of the ICE position at the junction point was stored and served as a reference when the PV ostia were tagged on the 3-D map.
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30W. PV isolation was performed during pacing
from the electrodes in the coronary sinus for the left-
sided PVs and during sinus rhythm for the right-
sided PVs. Since most patients complained of back
pain during the RF delivery to the posterior wall of
the LA, 7.5mg of pentazocine was administered
intravenously before the energy delivery. The abla-
tion catheter was moved from one point to another to
create linear encircling RF lesions around the left-
and right-sided PVs < 2 cm from the PV ostia
(Figure 3B). For the anterior aspect of the left PVs,
an encircling line was created along the PV-LA
junction, which consisted of the prominent ridge
between the PV and left atrial appendage. The RF
energy was delivered for at least 20 seconds at each
position. If high-frequency potentials were still
recorded with the circular catheters in the PVs even
after the completion of a circumferential line (the
completion of the line was deﬁned graphically on the
CARTO map), segmental ostial ablation was added,
guided by ostial PV potentials.
The endpoint of the procedure was the elimination
of the PV potentials. PV disconnection was con-
ﬁrmed by the loss of atrial capture during pacing
from the distal bipole of the ablation catheter
advanced into the pulmonary veins.
In 69 patients conduction block at the cavo-
tricuspid isthmus was also created by the application
of RF energy using an 8mm-tip ablation catheter
(EPT-5770TN4, Boston Scientiﬁc, San Jose, CA,
USA) through an 8F-sheath (RAMP, Daig Corp.
Minnetonka, MN, USA) after the PV isolation. No
diﬀerence in the type of AF or inducibility of atrial
ﬂutter after the PV isolation was observed between
the groups with and without cavo-tricuspid isthmus
ablation (CTIA).
At the end of the procedure, an intra-vascular
echogram of the PVs was obtained to evaluate
whether the ablation caused stenosis of the PVs.
Adjunctive pharmacotherapy
In 32 (45%), 15 (71%) and all patients with
paroxysmal, persistent and chronic AF, respectively,
the antiarrhythmic drugs prescribed before the
ablation were continued after the ablation. After 3
to 6 months the drugs were discontinued if there
were no recurrences of AF. The adjunctive antiar-
rhythmic drugs were as follows. Class I drugs in 28
patients (disopyramide 6, cibenzoline 3, aprindine 9
and pilsicainide 10), Class II in 12 (carvedilol 9,
atenorol 2 and bisoprolol 1), Class III in 4 (amio-
darone 4), and Class IV in 35 (bepridil 34, and
verapamil 1).
Follow-up
Outpatient follow-up occurred every month for 12
months and every 6 months thereafter. All patients
were administered warfarin to achieve an INR
between 1.5 and 2.5, for at least a month after the
ablation procedure. In the patients with paroxysmal
AF, the determination of whether the outcome of the
ablation was successful or not was determined by the
symptoms and ECG recordings, including the am-
bulatory ECG. ‘‘Success’’ was deﬁned as a patient
A   Tagging of the pulmonary vein ostia B   Encircling isolation of the PVs
Figure 3 Encircling pulmonary vein isolation.
Electroanatomic map of the LA in the postero-anterior view. A, The PV ostia were tagged by pink and orange dots under
ﬂuoroscopic guidance. B, Two circumferential ablation lesions (brown dots) around the ipsilateral PVs were created.
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having no episodes of symptomatic AF, and ‘‘im-
provement’’ as the duration and/or frequency of the
symptomatic AF episodes decreasing substantially
as compared with that before the ablation. In the
patients with persistent or chronic AF, maintenance
of sinus rhythm was conﬁrmed by recording the
ECG. The mean follow-up period was 10:4 6:0
months.
Results
Ablation procedure
In 27 out of 120 patients, completion of the
encircling lesions resulted in the loss of the PV
potentials in all the pulmonary veins. Figure 4 shows
that creating an encircling line around the left- and
right-sided PVs was associated with a simultaneous
disappearance of the PV potentials in the ipsilateral
superior and inferior PVs, indicating PV disconnec-
tion. In the rest of the patients, however, the PV
potentials persisted in the recordings from the Lasso
catheters in at least one PV even after completion of
the encircling line. In these patients segmental ostial
isolation was performed guided by circular mapping
catheters (Figure 5). Usually RF applications at one
or two ostial sites eliminated the residual PV
potentials. There was no diﬀerence in the patient
characteristics between the two groups with and
without the need for additional ostial PV isolation
except that the proportion of males was larger in the
combined therapy group (male/female, CPI: 17/10
vs. CPIþ SOPI: 79/14).
100ms
A   Disappearance of PV potentials (left PVs) B   Pacing from the LSPV
C   Pacing from the LIPV D   Disappearance of PV potentials (right PVs)
100ms 100ms
100ms
Figure 4 LA-PV disconnection by encircling pulmonary vein isolation.
A, The tracings are the surface leads II and V1, and the intracardiac electrograms recorded from a catheter inside the coronary sinus (Cs),
ablation catheter (ABL) and 2 Lasso catheters positioned in the left superior pulmonary vein (LSPV) and left inferior pulmonary vein
(LIPV) during pacing from the distal Cs electrode pair. Completion of an encircling line around the left-sided PVs resulted in the
simultaneous disappearance of the PV potentials (white arrows) in the LSPV and LIPV (red arrow), indicating conduction block between
the left atrium and PVs during pacing from the distal Cs electrode pair. B, Pacing from a Lasso catheter within the LSPV captured the
spike-potentials (white arrows) recorded from the Lasso catheters in the LS- and LIPV but not the atrial electrograms (A) recorded from
the Cs catheter. C, Pacing from the Lasso catheter within the LIPV captured the spike-potentials (white arrows) recorded from the Lasso
catheters in the LS- and LIPV but not the atrial electrograms (A) recorded from the Cs catheter. D, The tracings are those of the surface
leads II and V1, and intracardiac electrograms recorded from a catheter inside the Cs, ablation catheter (ABL) and 2 Lasso catheters
positioned in the RSPV and RIPV during pacing from an electrode pair in the right atrium in the same patients shown in panels A–C.
Completion of an encircling line around the right-sided PVs also eliminated the PV potentials (white arrows) in the RSPV and RIPV
simultaneously (red arrow).
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The total procedure and ﬂuoroscopy times were
242 72 and 121 42 minutes, respectively.
Outcome
The outcome of the ablation was evaluated > 1
month after the ablation. Since several patients had
episodes of paroxysmal AF during the one month
just after the ablation and no recurrence thereafter,
recurrence of AF in that period was censored. The
outcome of the ablation is shown in Table 2. In all,
81.7%, 90.5% and 71.4% of the patients with
paroxysmal, persistent and chronic AF, respectively,
were free of AF. Fourteen percent of the patients
with paroxysmal AF had a greatly reduced frequency
and/or duration of the episodes of AF as compared
to those before the ablation (deﬁned as ‘‘improve-
ment’’). There was no diﬀerence in the outcome
between the groups with CPI only and those with
CPIþ SOPI (success/improvement/no improve-
ment, CPI: 81.5/7.4/11.1 vs. CPIþ SOPI: 80.6/
8.6/10.8%) or between those with and without cavo-
tricuspid isthmus ablation (success/improvement/no
improvement, CTIA (+) 84.1/8.7/7.2 vs. CTIA ()
76.5/7.8/15.7%).
100ms
Figure 5 Segmental ostial pulmonary vein isolation.
The tracings are those of the surface leads II and V1, and the intracardiac electrograms recorded from a catheter inside the coronary sinus
(Cs), ablation catheter (ABL) and 2 Lasso catheters positioned in the left superior pulmonary vein (LSPV) and left inferior pulmonary vein
(LIPV) during pacing from the distal Cs electrode pair. After completion of an encircling line around the left-sided PVs, the PV potentials
(white arrows) in the LSPV remained while the PV potentials in the LIPV disappeared. The earliest activation of the PV potentials in the
LSPV was recorded at electrode pair LSPV 15–16 of the Lasso catheter (blue arrow). An application of radiofrequency energy to the
earliest activation site eliminated the PV potentials in the LSPV (red arrow).
Table 2 Outcome of combined ablation therapy for treating
AF.
Improvement Success No improvement Total
58 (40)
Paroxysmal 10 (6) 81.7% 3 (0) 71 (46)
% 14.1% (8.5%) (56.3%) 4.2% (0%)
19 (7)
Persistent 90.5% 2 (0) 21 (7)
% — (33.3%) 9.5% (0%)
20 (5)
Chronic 71.4% 8 (0) 28 (5)
% — (17.9%) 28.6% (0%)
( ): free of antiarrhythmic drugs
One patient in whom electrical cardioversion was performed 1
week after the ablation was included.
J Arrhythmia Vol 22 No 4 2006
230
Twenty-two patients with persistent or chronic
AF, in whom sinus rhythm was maintained after the
ablation, were taking bepridil, and 4 of those patients
were receiving aprindine in addition to the bepridil.
One patient with chronic AF in whom AF recurred 1
week after the ablation procedure underwent elec-
trical cardioversion and maintained sinus rhythm
thereafter.
Repeat ablation procedures
A repeat ablation was performed in 3 patients. In 2
patients recovered connections between the LA and
all four PVs were found. These PV potentials were
delayed markedly and eliminated by segmental ostial
ablation without any further recurrence of AF. In the
other patient, a left atrial ﬂutter was treated with
linear ablation between the mitral annulus and right
superior PV in a second session.
Complications
Five patients developed atrial tachycardia. In two
patients, the impulse of the tachycardia propagated
around the mitral valve. The tachycardia was treated
successfully with a linear ablation between the mitral
annulus and right superior PV in one patient in the
second session and between the mitral annulus and a
scar near the left superior PV in the other patient at
the end of the ﬁrst session. Two of the other three
patients underwent electrical cardioversion. These
three patients were prescribed an antiarrhythmic
therapy for 3 months and the medications were
discontinued thereafter without any recurrence of the
atrial tachycardia. Atrial tachycardia after PV iso-
lation occurred in 3.7% of the patients with CPI only
and 4.3% of the patients with CPIþ SOPI. The
diﬀerence was not statistically signiﬁcant.
Two patients had cardiac tamponade during the
ablation that needed pericardial drainage. No PV
stenosis > 25% was observed.
Discussion
Main ﬁndings
In this study, the combination of extensive
encircling isolation and segmental ostial isolation
in patients with paroxysmal, persistent and chronic
AF resulted in a comparable outcome to that of the
previous reports where encircling PV isolation was
performed to eliminate AF.5–11) Although there were
several complications in the present study, no fatal
complications, such as a perforation of the esoph-
agus, were observed. These ﬁndings suggest that the
combination of encircling PV isolation and supple-
mental segmental ostial ablation is eﬃcient, feasible
and safe for the treatment of patients with drug
refractory AF.
Segmental vs. circumferential PV isolation
Many reports have shown that segmental ostial PV
isolation is useful in curing paroxysmal AF.1–4)
Recently, however, anatomical circumferential PV
isolation has been shown to be more eﬀective in
preventing AF recurrence.5–11) Oral et al. directly
compared the eﬃcacy of segmental ostial isolation
and circumferential isolation of the PVs.6) In their
report the AF free survival rate was higher and the
number of repeated sessions was smaller for the
circumferential PV isolation as compared to the
segmental ostial PV isolation. The advantage of the
circumferential PV isolation over the segmental
PV isolation was attributed to several eﬀects: (1)
elimination of the extra PV foci near the PV ostia,
(2) abolition of anchor points for rotors or mother
waves that drive AF, (3) reduction of the left atrial
myocardium that provides the area available for
circulating wavelets during AF, and (4) vagal
denervation of the atria.5–10)
Most recurrences of AF after PV isolation are due
to recovery of the conduction between the left atrium
and pulmonary veins.10) Using basket catheters to
record potentials at the PV ostia, Yamada et al.
reported that reconnection of the LA and PV occurs
at the edge of previously ablated segments in
patients with AF recurrence after segmental ostial
PV isolation.12) When the muscle strands connecting
the LA and PV are burned segmentally, the edges of
the ablated segments may become electrically inert
giving the false presumption that permanent con-
duction block is achieved. After some period of
hibernation the muscle ﬁbers may recover to conduct
impulses, thus triggering or perpetuating AF. Con-
tinuous circular PV isolation would preclude this
‘‘edge eﬀect.’’ This may provide another explanation
for the better outcome of circumferential PV
isolation than segmental ostial isolation in prevent-
ing AF recurrence.
In the present study PV isolation was achieved in
as much as 23% of the patients (27 out of 120
patients) with CPI only. Additional RF applications
to the PV ostia (SOPI) were often required to
complete the PV isolation. In the SOPI performed
after CPI, the number of ablation sites was limited
to one or two. During the CPI most of the atrial
muscle strands connecting the left atrium and PVs
would have been ablated. The residual PV potentials
after the CPI indicated a gap in the circumferential
line, suggesting that some connecting muscle
strands were not ablated. SOPI would have dis-
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rupted this residual atrium-PV connection at a more
ostial side.
Adjunctive drug therapy
Although the outcome of the present study was
comparable to that of the previous reports where
the PVs were isolated circumferentially, 66.7% and
82.1% of patients with persistent and chronic AF,
respectively, were taking antiarrhythmic drugs.
Fujiki et al. reported a high pharmacological con-
version rate by bepridil, a unique Ca-antagonist that
also blocks potassium channels and prolongs the
action potentials of the heart muscle, in patients with
persistent AF.13) They also reported that a combined
therapy with aprindine and bepridil improved the
success rate of the pharmacological cardioversion.
In the present study 22 patients with persistent or
chronic AF, in whom sinus rhythm was maintained
after the ablation, were taking bepridil, and 4 of
those patients were receiving aprindine in addition
to the bepridil. Maintaining sinus rhythm in those
patients may have beneﬁted from those drugs.
Nevertheless, considering that the patients in the
present study were selected for ablation because of
drug-resistant AF with a failure of pharmacological
or repeated electrical cardioversions, the usefulness
of the ablation therapy is worth mentioning.
RF energy
In most of the reports on encircling isolation, an
8mm-tip catheter or irrigation catheter was utilized
and the target energy was set at >50 watts,5–10)
because a greater energy was required to complete
the continuous lesions on the atrial side around the
PVs as compared to segmental ostial isolation. It was
reported that even the deployment of an 8mm-tip
catheter and a high energy setting was often
insuﬃcient to create complete circumferential block
lines around the PVs.11,14) Although the complication
rate is acceptably low in the anatomical circum-
ferential isolation of PVs, several devastating in-
advertent consequences such as perforation of the
esophagus have been reported.15,16) This may result
from the higher energy settings needed to pursue
complete isolation of the PVs. Pappone et al.
suggested that lower power and temperature settings
for the RF energy applications along the posterior
wall may prevent further cases of ﬁstula forma-
tions.16) Thus, complete isolation of the PVs and a
lower target energy delivery for safety are creating a
dilemma for circumferential PV isolation. In the
present study the ablation energy was limited to
<30W and 55 C, which are settings that may
reduce the risk of an esophageal perforation. The
lower target energy and use of a 4mm-tip ablation
catheter in the present study may account for the
low success rate of the PV isolation (disappearance
of the PV potentials) when the PV isolation was
performed by an encircling procedure only on the
atrial side.11) However, supplemental segmental
applications of RF energy at the PV ostia eliminated
the PV potentials achieving a good outcome in
preventing the recurrence of AF. The combination of
an encircling PV isolation with lower energy and
temperature settings and supplemental segmental
ostial isolation may provide a safe and eﬃcient
solution for the treatment of atrial ﬁbrillation.
Atrial tachycardia
It has been reported that an organized left atrial
tachycardia occurs as a proarrhythmic complication
of extensive left atrial ablation after PV isola-
tion.6,17–19) It was inferred that this was due to the
formation of an isthmus delineated by block lines of
conduction created by linear RF lesions.17–19) On the
other hand, other reports have shown that most of
the atrial tachycardias after PV isolation are focal
tachycardias which originate from the reconnected
segments of prior isolated PVs.10,20) In two patients
in the present study, the atrial tachycardia observed
after the ablation was a left atrial ﬂutter which was
treated by linear ablation in the left atrium. In the
remaining three patients, no treatment was needed
after the initial 3 months of follow-up. Recurrence of
AF and irregular atrial tachycardias were not
included in the post-ablation atrial tachycardias in
the present study. The present results and other
reports show that atrial tachycardia associated with
circumferential PV isolation can be treated success-
fully with ablation therapy or resolves without
treatment.
Limitations
The evaluation of the outcome of the ablation
therapy in the present study depended mostly on the
symptoms in the patients with paroxysmal AF. This
may have resulted in an overestimation of the AF-
free patients after the ablation in this group. How-
ever, considering that the patients with paroxysmal
AF in the present study were highly symptomatic
before the ablation, it seems reasonable to assume
that the ‘‘symptom-free’’ patients could be regarded
as surrogates for ‘‘AF-free patients’’ to some extent.
The mean duration of the follow-up was ten
months. Further studies will be needed to determine
the long-term eﬃcacy and safety of this combined
therapy.
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